| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.004 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |